At home testing available

OneTest™ – Multi-Cancer Test – NCFW

Original price was: $189.00.Current price is: $142.50.

OneTest™ helps detect cancers earlier, at more treatable stages with one simple blood test.
A simple blood test for multiple cancers, harnesses the power of Artificial Intelligence to help identify the disease at an earlier, more treatable stage.

OneTest™ requires a physician’s authorization and one (1) tube of blood. Your OneTest™ collection kit will be mailed  to you after your purchase

Why use OneTest™?

It can help with early detection of lung, liver, pancreas, and other cancers that are not widely screened for in the United States.

Broad cancer screening for the most common types of cancer is available in many countries, however, in the US, cancer screening is normally limited to colon cancer, plus breast and cervical cancer for women, and prostate cancer for men. OneTest is now available in the US to screen for multiple types of cancers, including lung, liver, pancreatic, ovarian, prostate, kidney and others.  

We measure tumor antigens (not genes) which can help detect cancer now, not in the future

Many popular DNA testing companies today offer not only ancestry analysis, but also tests for inherited genetic abnormalities that pre-dispose the consumer to various diseases. Such tests have very limited value for early cancer detection since recent studies have confirmed that fewer than 5% of the genetic mutations that cause cancer are inherited. Instead, most cancer-causing mutations result from random DNA copying errors over time.  

Our algorithms provide better accuracy than tumor markers alone. 

We use machine learning to compare biomarker levels and other characteristics such as age and gender with a vast database of  28,000 subjects tested over 12 years. This approach has been demonstrated to help detect nearly twice as many cancers as biomarker testing alone. (See Accuracy, Reliability & Scientific Support for more details.)  

OneTest™ is powered and validated by real-world data from asymptomatic individuals

Most biomarker-based cancer tests are developed and validated using stored laboratory blood samples from cancer patients. The purported accuracy of these tests usually drops considerably when they are later used in a real-world screening setting (i.e. Individuals without signs or symptoms of cancer).

Silent Progression vs. Early Insight: 
The OneTest™ Advantage

Cancer doesn’t announce itself. By the time symptoms appear, critical months of treatment opportunity have been lost forever.

THE TRADITIONAL PATH

Cancer begins forming
Invisible to standard tests
3-9 months pass silently on average
Cancer continues to grow undetected
Symptoms finally appear
Often when cancer has advanced
Cancer diagnosed (often Stage 2-4)
More difficult to treat
5-year survival rates dramatically reduced

Early Detection Advantage

Cancer begins forming
OneTest™ detects biomarker changes
Identifies potential issues early
Early intervention possible
Before symptoms even appear
Treatment at earliest stages
When it's most effective
Provides best chance to improve outcomes

Why Customers Chose OneTest™

Frequently Asked Questions

Is OneTest a replacement for regular cancer screenings?

OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.

OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.

OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.

OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.

Shopping Basket